Deposition and metabolism of inhaled ciclesonide in the human lung
Authors:
Open Access
- 29 March 2010
- journal article
- clinical trial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 36 (5) , 1113-1119
Abstract
Ciclesonide is an inhaled corticosteroid, administered as a prodrugviaa metered-dose inhaler. Following deposition in the lung, ciclesonide is hydrolysed by esterases to form the pharmacologically active metabolite desisobutyryl-ciclesonide (des-CIC). Formation of des-CIC, as well as reversible esterification of des-CIC with fatty acids, has been demonstratedin vitro. The aim of this study was to investigate thein vivometabolism of ciclesonide in the human lung.This single-dose, open-label, nonrandomised study was performed in 20 patients undergoing planned lung surgery for treatment of malignant pulmonary lesions. Patients inhaled a single dose of 1,280 μg ciclesonide at various time-points between 2 and 24 h prior to lung tissue resection. The concentration of ciclesonide, des-CIC and fatty acid conjugates of des-CIC in tissue samples was determined. Serum samples for pharmacokinetic analysis were taken at several time-points after inhalation.The pharmacokinetics in serum indicated that the inhalation by the patients was adequate. Metabolites (des-CIC, des-CIC oleate and des-CIC palmitate) were detected in the resected central and peripheral lung tissues. A substantial portion of ciclesonide was already activated to des-CIC at the first time-point of tissue analysis.Activation of ciclesonide and formation of des-CIC fatty acid conjugates was confirmedin vivoin the human lung.Keywords
This publication has 28 references indexed in Scilit:
- Sensitive simultaneous determination of ciclesonide, ciclesonide-M1-metabolite and fluticasone propionate in human serum by HPLC–MS/MS with APPIJournal of Chromatography B, 2008
- The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissueBiochemical Pharmacology, 2007
- In Vitro metabolism of ciclesonide in human lung and liver precision‐cut tissue slicesBiopharmaceutics & Drug Disposition, 2006
- High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthmaRespiratory Medicine, 2006
- Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonidePulmonary Pharmacology & Therapeutics, 2005
- Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5′monophosphate in asthmatic patientsPulmonary Pharmacology & Therapeutics, 2005
- Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjectsEuropean Journal of Clinical Pharmacology, 2005
- Direct measurement of BDP and 17-BMP in bronchial and peripheral lung tissue after inhalation of HFA- vs CFC-driven aerosolsPulmonary Pharmacology & Therapeutics, 2004
- PrefaceJournal of Allergy and Clinical Immunology, 2002
- Relationship between lung tissue and blood plasma concentrations of inhaled budesonideBiopharmaceutics & Drug Disposition, 1993